 AN EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY, TOLERABILITY AND EFFICACY OF DALFAMPRIDINE EXTENDED-RELEASE TABLETS FOR THE TREATMENT OF CHRONIC POST-ISCHEMIC STROKE WALKING DEFICITS IN SUBJECTS WHO PARTICIPATED IN THE DALF-PS-1016 STUDY: 